Stock futures higher as
beaten down tech stocks rebound
Send a link to a friend
[June 19, 2017]
By Tanya Agrawal
(Reuters) -
U.S.
stock index futures were higher on Monday with investors snapping up
beaten down technology and retail stocks.
The S&P technology sector is coming off its second straight week
of declines, triggered mainly due to stretched valuations and investors
moving money to other sectors. Tech stocks have led the S&P 500's 8.7
percent rally this year.
Leading the rebound, Apple, Microsoft and Alphabet were all up between
0.8 percent and 1 percent in premarket trading.
Retail stocks were battered on Friday after Amazon.com's $13.7 billion
deal to buy upscale grocer Whole Foods.
The deal by Amazon, a proven retail disruptor, marked a major step by
the internet retailer into the brick-and-mortar retail sector.
Amazon was up 0.94 percent, while Wal-Mart, Target and Kroger gained
between 0.4 percent and 1.1 percent on Monday.

The market is awaiting comments by New York Fed President William
Dudley, a close ally of Fed Chair Janet Yellen, when he speaks at a
business roundtable at 7:45 a.m. ET (1145 GMT).
Yellen's confidence as her team raised interest rates for the third time
in six months last week surprised investors who had expected more
caution about the economy following a batch of weak U.S. economic data.
[to top of second column] |

Traders work on the floor of the New York Stock Exchange (NYSE) in
New York, U.S., June 2, 2017. REUTERS/Brendan McDermid

Last
month, the U.S. economy added 138,000 jobs, well below the expected gain of
185,000, while other data showed a fall in retail sales and inflation below the
Fed's target of 2 percent.
European stocks were headed for their biggest rise in two months, helped by a
meaty parliamentary majority for pro-business French President Emmanuel Macron.
Oil prices edged higher, after coming under pressure over the past month from
rising production. [O/R]
Clovis Oncology <CLVS.O> soared 41.8 percent to $85 after the biotechnology
company's ovarian cancer drug was set for a label expansion.
(Reporting by Tanya Agrawal; Editing by Saumyadeb Chakrabarty)
[© 2017 Thomson Reuters. All rights
reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |